New Hope, PA, United States of America

Cynthia Anne Maryanoff

This inventor holds 43 USPTO granted patents, plus 3 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Mcneil Ab, Ortho-Mcneil Pharmaceutical Corp., Cordis Corporation. Active years: 1985-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cynthia Anne Maryanoff. Retrieved from https://idiyas.com/inventor/cynthia-anne-maryanoff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 95.3



Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 130(Granted Patents)


Location History:

  • Solebury Township, PA (US) (1989)
  • Solebury Township, Bucks County, PA (US) (1987 - 1990)
  • Buckingham Township, PA (US) (2002 - 2007)
  • New Hope, PA (US) (1985 - 2012)
  • Forest Grove, PA (US) (2000 - 2012)

Company Filing History:


Years Active: 1985-2012

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Peptide Synthesis
Anticonvulsant Derivatives
Medical Device Coatings
Fructopyranose Derivatives
Cyclopentane Derivatives
MALDI Mass Spectrometry
Sulfamate Derivatives
Prostatic Hyperplasia Treatments
Amidine Sulfonic Acids
3-Amino Propanoates
Hexahydro Isoquinolines
43 patents (USPTO):Explore Patents

Title: Cynthia Anne Maryanoff: Innovator in Liquid Phase Peptide Synthesis

Introduction

Cynthia Anne Maryanoff is a prominent inventor based in New Hope, PA, with an impressive portfolio of 43 patents to her name. Her work primarily focuses on innovations in the field of peptide synthesis and molecular imaging, contributing significantly to medical technology and pharmaceuticals.

Latest Patents

Among her notable patents is an invention related to the "Liquid phase peptide synthesis of KL-4 pulmonary surfactant." This innovation pertains to advanced processes for the production of the 21 residue protein component, (Lys-Leu)-Lys, which plays a crucial role in pulmonary surfactant KL-4. The process is designed for large-scale synthesis, utilizing a method of saponifying an ester that minimizes the racemization of the α-carbon. Another significant patent is for "Sample plate designs for MALDI and DESI for molecular imaging of coated medical devices on the applied biosystems Qstar/Voyager MALDI mass spectrometer." This invention involves holding devices that securely hold medical devices, such as stents, which are essential for conducting molecular imaging studies.

Career Highlights

Cynthia has made substantial contributions to the pharmaceutical industry through her work at well-known companies. Notable among these are McNeil AB and Ortho-McNeil Pharmaceutical Corporation, where she has played a key role in developing innovative solutions for medical applications.

Collaborations

Throughout her career, Cynthia has collaborated with esteemed colleagues, including Ahmed F Abdel-Magid and Frank John Villani, Jr. These partnerships have fostered an exchange of ideas and advancements in research and development, further enhancing the impact of her work in the field.

Conclusion

Cynthia Anne Maryanoff stands out as a leading inventor whose contributions to liquid phase peptide synthesis and molecular imaging have significantly advanced medical technology. Her dedication to innovation and collaboration continues to influence the industry positively, paving the way for future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…